Maximus, Inc. (NYSE:MMS) Holdings Raised by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. grew its stake in shares of Maximus, Inc. (NYSE:MMS) by 21.6% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,198 shares of the health services provider’s stock after acquiring an additional 923 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Maximus were worth $445,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. Vanguard Personalized Indexing Management LLC acquired a new stake in Maximus during the fourth quarter valued at $431,000. Robeco Institutional Asset Management B.V. lifted its holdings in shares of Maximus by 28.7% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 11,127 shares of the health services provider’s stock valued at $933,000 after buying an additional 2,483 shares during the last quarter. Norges Bank bought a new stake in shares of Maximus in the 4th quarter valued at approximately $55,821,000. UBS Group AG increased its holdings in Maximus by 60.7% in the fourth quarter. UBS Group AG now owns 72,724 shares of the health services provider’s stock worth $6,099,000 after buying an additional 27,466 shares during the last quarter. Finally, Coldstream Capital Management Inc. bought a new position in Maximus during the fourth quarter valued at approximately $210,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Stock Performance

MMS stock opened at $89.98 on Friday. The firm has a 50 day moving average of $89.75 and a two-hundred day moving average of $86.10. Maximus, Inc. has a 12 month low of $72.39 and a 12 month high of $93.97. The company has a market capitalization of $5.47 billion, a price-to-earnings ratio of 23.62 and a beta of 0.76. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.61.

Maximus (NYSE:MMS) last posted its earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.27. The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 20.91% and a net margin of 5.59%. The business’s revenue was up 10.6% compared to the same quarter last year. During the same period last year, the company earned $0.78 earnings per share. As a group, equities analysts anticipate that Maximus, Inc. will post 6.12 EPS for the current fiscal year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th were given a dividend of $0.30 per share. The ex-dividend date was Thursday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.33%. Maximus’s payout ratio is currently 31.50%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.